Diaphragmatic pacing is a treatment that improves breathing for people who rely on a mechanical ventilator. It stimulates the phrenic nerve, the nerve in your neck that sends signals to your diaphragm ...

The pacemaker, called the NeuRx Diaphragm Pacing System, zaps the diaphragm muscles to help people with spinal cord injuries breathe. People with ALS have used it since 2011 thanks to a Food and Drug ...

The TransAeris® Diaphragm Pacing System (DPS) has neither been cleared or approved for the indication to assist in weaning patients off ventilators in healthcare settings during the COVID-19 ...

The global Diaphragm Pacing Therapy System Market is experiencing growth, with projections indicating a continued upward trajectory and a compound annual growth rate (CAGR) of 4.06% through 2028.

Diaphragmatic dysfunction is an underdiagnosed cause of dyspnea and should always be considered in the differential diagnosis of unexplained dyspnea. 7–9 Dysfunction of the diaphragm ranges from ...

Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...

The NeuRX Diaphragm Pacing System costs hospitals $36,000, Ignagni said. He was unable to say what patients pay, because that cost varies from hospital to hospital.

Synapse Biomedical's diaphragm pacing system has won premarket approval from the Food & Drug Administration.

Diaphragmatic pacing. This is a method of restoring phrenic nerve function. If the phrenic nerve is intact but not working, an electronic pacer can be implanted in the body and attached to it.